Finance

Beta
Lists
CRWV:NASDAQ
CoreWeave Inc
$96.58
-2.21%
(-2.18) 1D
$98.73
+2.23% (+2.15)
Pre-market
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRWV...
Open
$95.18
High
$98.09
Low
$93.50
Mkt. cap
52.69B
Avg. vol.
29.15M
Volume
159.98K
52-wk high
$173.35
52-wk low
$63.80
EPS
-$3.26
Shares outstanding
447.57M
No. of employees
2K
Open
$95.18
High
$98.09
Low
$93.50
Mkt. cap
52.69B
Avg. vol.
29.15M
Volume
159.98K
52-wk high
$173.35
52-wk low
$63.80
EPS
-$3.26
Shares outstanding
447.57M
No. of employees
2K
News stories
From sources across the web
Profile
CoreWeave, Inc. is an American artificial intelligence cloud-computing company based in Livingston, New Jersey. It specializes in providing cloud-based graphics processing unit infrastructure to AI developers and enterprises, and also develops its own chip management software. Founded as Atlantic Crypto in 2017 and focused on high-performance computing, CoreWeave has its own data centers operating in the United States and Europe, with some dedicated to multiple companies and some to a single client. Its $1.6 billion supercomputer data center for Nvidia in Plano, Texas, has been described by Nvidia as the fastest AI supercomputer in the world. Wikipedia
About CoreWeave Inc
CEO-
Employees2.19K
Founded2017
HeadquartersLivingston, New Jersey, United States
SectorInternet
Websitecoreweave.com
Analyst ratings
Based on 24 analysts giving stock ratings to CRWV in the past 3 months
Buy
Buy
14
Hold
9
Sell
1
12-month forecast
Based on 24 Wall Street analysts offering 12 month price targets for CRWV in the last 3 months.
Highest
Current $96.58
$167.00 (+72.91%)
Average
$132.35 (+37.04%)
Lowest
$67.00 (-30.63%)
Analyst
Recommendation
Action
Price target
Projected
Date
John McPeake
Rosenblatt Securities
Buy
Initiated
-
-
06/24/2026
Brett Knoblauch
Cantor Fitzgerald
Buy
Maintained
$167.00
+72.9%
06/15/2026
Madison Rezaei
Bernstein
Sell
Maintained
$67.00
-30.6%
06/08/2026
Unknown Analyst
Exane BNP Paribas
Buy
Initiated
-
-
06/02/2026
Matthew Niknam
Truist Financial
Hold
Maintained
-
-
05/28/2026
Nehal Chokshi
Northland Securities
Buy
Reiterated
$165.00
+70.8%
05/22/2026
Alex Platt
D.A. Davidson
Hold
Downgraded
$100.00
+3.5%
05/18/2026
Gil Luria
D.A. Davidson
Hold
Downgraded
$100.00
+3.5%
05/18/2026
Tyler Radke
Citi
Buy
Reiterated
$158.00
+63.6%
05/14/2026
Gabriela Borges
Goldman Sachs
Hold
Maintained
$121.00
+25.3%
05/11/2026
Raimo Lenschow
Barclays
Hold
Reiterated
$120.00
+24.2%
05/11/2026
Brad Zelnick
Deutsche Bank
Buy
Maintained
$135.00
+39.8%
05/08/2026
Rohit Kulkarni
Roth MKM
Buy
Reiterated
$150.00
+55.3%
05/08/2026
Keith Weiss
Morgan Stanley
Hold
Maintained
$99.00
+2.5%
05/08/2026
Param Singh
Oppenheimer
Buy
Reiterated
$150.00
+55.3%
05/08/2026
Mark Murphy
J.P. Morgan
Hold
Reiterated
$105.00
+8.7%
05/08/2026
Mike Cikos
Needham
Hold
Maintained
-
-
05/08/2026
Michael Turrin
Wells Fargo
Buy
Reiterated
$155.00
+60.5%
05/08/2026
Arvind Ramnani
Truist Financial
Hold
Maintained
$131.00
+35.6%
05/08/2026
Gregg Moskowitz
Mizuho Securities
Hold
Reiterated
$110.00
+13.9%
05/08/2026
Ruben Roy
Stifel Nicolaus
Hold
Maintained
$120.00
+24.2%
05/08/2026
Brent Thill
Jefferies
Buy
Maintained
$160.00
+65.7%
05/08/2026
Amit Daryanani
Evercore ISI
Buy
Maintained
$150.00
+55.3%
05/05/2026
Tal Liani
Bank of America Securities
Buy
Reiterated
$140.00
+45%
05/05/2026
Alex Zukin
Wolfe Research
Buy
Initiated
$150.00
+55.3%
04/16/2026
Paul Golding
Macquarie
Buy
Upgraded
$125.00
+29.4%
04/12/2026
Nick Del Deo
MoffettNathanson
Hold
Maintained
$92.00
-4.7%
03/09/2026
Kevin Dede
H.C. Wainwright
Buy
Reiterated
$180.00
+86.4%
03/02/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.12 / -$0.91
-22.75%miss
Revenue / Est. (USD)
2.08B / 1.97B
+5.27%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.21B
1.36B
1.57B
2.08B
Cost of goods sold
312.67M
368.82M
509.12M
716.00M
Cost of revenue
312.67M
368.82M
509.12M
716.00M
Research and development expenses
669.91M
747.48M
950.21M
1.27B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
182.00M
196.52M
202.17M
233.00M
Operating expense
851.91M
944.00M
1.15B
1.51B
Total operating expenses
1.16B
1.31B
1.66B
2.22B
Operating income
48.21M
51.85M
-89.59M
-144.00M
Other non operating income
21.74M
8.07M
24.48M
24.00M
EBT including unusual items
-242.73M
-236.80M
-466.86M
-656.00M
EBT excluding unusual items
-213.73M
-248.80M
-451.86M
-656.00M
Income tax expense
47.78M
-126.68M
-15.13M
84.00M
Effective tax rate
-19.68%
53.50%
3.24%
-12.80%
Other operating expenses
-
-
-
-
Net income
-290.51M
-110.12M
-451.73M
-740.00M
Net profit margin
-23.95%
-8.07%
-28.74%
-35.61%
Earnings per share
-0.27
-0.08
-0.56
-1.12
Interest and investment income
6.00M
9.00M
10.00M
-
Interest expense
-266.97M
-310.56M
-387.64M
-536.00M
Net interest expenses
-260.97M
-301.56M
-377.64M
-536.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
607.69M
682.33M
730.95M
1.00B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CRWV
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer